Acquired
Novo Nordisk (Ozempic)
David Rosenthal
You can't just put more regular human GLP-1 in the body or it's going to go away immediately. So a whole lot of people across the industry kind of bang their heads against the wall. Nobody can figure out how to make this work. And the industry and the academic research community pretty much abandons it as a drug candidate. But Lata is like, if we could make it work.
0
💬
0
Comments
Log in to comment.
There are no comments yet.